Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 105692

1.

Indocyanine Green guided pelvic lymph node dissection. An efficient technique to classify the lymph node status of patients with prostate cancer who underwent radical prostatectomy.

Ramírez-Backhaus M, Mira Moreno A, Gómez Ferrer A, Calatrava Fons A, Casanova J, Solsona Narbón E, Ortiz Rodríguez IM, Rubio Briones J.

J Urol. 2016 May 25. pii: S0022-5347(16)30511-0. doi: 10.1016/j.juro.2016.05.087. [Epub ahead of print]

PMID:
27235788
2.

Correlations Between Cutaneous Malignant Melanoma and Other Cancers: An Ecological Study in Forty European Countries.

Serrano PF, Serrano JL, Allam MF, Navajas RF.

Int J Prev Med. 2016 May 4;7:73. doi: 10.4103/2008-7802.181759. eCollection 2016.

3.

Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy.

Kobayashi T, Kimura T, Lee C, Inoue T, Terada N, Kono Y, Kamba T, Kim CS, Egawa S, Ogawa O.

Jpn J Clin Oncol. 2016 May 20. [Epub ahead of print]

PMID:
27207889
4.

Magnetic resonance/transrectal ultrasound fusion biopsy of the prostate compared to systematic 12-core biopsy for the diagnosis and characterization of prostate cancer: multi-institutional retrospective analysis of 389 patients.

Mariotti GC, Costa DN, Pedrosa I, Falsarella PM, Martins T, Roehrborn CG, Rofsky NM, Xi Y, M Andrade TC, Queiroz MR, Lotan Y, Garcia RG, Lemos GC, Baroni RH.

Urol Oncol. 2016 May 16. pii: S1078-1439(16)30018-7. doi: 10.1016/j.urolonc.2016.04.008. [Epub ahead of print]

PMID:
27197921
5.

The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients.

Kim CS, Theeuwes A, Kwon DD, Choi YD, Chung BH, Lee HM, Lee KH, Lee SE.

Investig Clin Urol. 2016 May;57(3):174-83. doi: 10.4111/icu.2016.57.3.174. Epub 2016 May 10.

6.

Potential role for metformin in urologic oncology.

Sayyid RK, Fleshner NE.

Investig Clin Urol. 2016 May;57(3):157-64. doi: 10.4111/icu.2016.57.3.157. Epub 2016 May 10. Review.

7.

Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?

Faletti R, Battisti G, Discalzi A, Grognardi ML, Martinello S, Oderda M, Gontero P, Bergamasco L, Cassinis MC, Fonio P.

Abdom Radiol (NY). 2016 May;41(5):926-33. doi: 10.1007/s00261-015-0574-x.

PMID:
27193791
8.

Increased consultation frequency in primary care, a risk marker for cancer: a case-control study.

Ewing M, Naredi P, Nemes S, Zhang C, Månsson J.

Scand J Prim Health Care. 2016 May 18:1-8. [Epub ahead of print]

PMID:
27189513
9.

Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.

Davis R, Salmasi A, Koprowski C, Kim S, Kwon YS, Faiena I, Patel N, Elsamra SE, Kim IY.

Clin Genitourin Cancer. 2016 Apr 22. pii: S1558-7673(16)30100-8. doi: 10.1016/j.clgc.2016.04.010. [Epub ahead of print]

PMID:
27188968
10.

Hepatocyte Differentiation Markers in Adenocarcinoma of the Prostate: HepPar-1 but not Arginase-1 is specifically expressed in a Subset of Prostatic Adenocarcinoma.

Giedl J, Büttner-Herold M, Wach S, Wullich B, Hartmann A, Agaimy A.

Hum Pathol. 2016 May 13. pii: S0046-8177(16)30065-X. doi: 10.1016/j.humpath.2016.04.016. [Epub ahead of print]

PMID:
27184483
12.

Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation Therapy.

Jeon JC, Park J, Park S, Moon KH, Cheon SH, Park S.

World J Mens Health. 2016 Apr;34(1):28-33. doi: 10.5534/wjmh.2016.34.1.28. Epub 2016 Apr 30.

13.

Seminal Vesicle Leiomyoma Mimicking Extra-prostatic Extension of Prostatic Adenocarcinoma.

Arnold SJ, Lin FC, Eldersveld JM, Phung MC, Walker JR, Nguyen TT.

Urol Case Rep. 2016 Feb 23;6:18-20. doi: 10.1016/j.eucr.2016.01.005. eCollection 2016 May.

14.

A 76 year old male with an unusual presentation of merkel cell carcinoma.

Acab JC, Kvatum W, Ebo C.

Int J Surg Case Rep. 2016 May 3;23:177-181. doi: 10.1016/j.ijscr.2016.04.041. [Epub ahead of print]

15.

Evaluation of pelvic floor muscle strength before and after robotic-assisted radical prostatectomy and early outcomes on urinary continence.

Manley L, Gibson L, Papa N, Beharry BK, Johnson L, Lawrentschuk N, Bolton DM.

J Robot Surg. 2016 May 9. [Epub ahead of print]

PMID:
27160677
16.

Magnetic Resonance Microscopy May Enable Distinction Between Normal Histomorphological Features and Prostate Cancer in the Resected Prostate Gland.

Durand M, Jain M, Robinson B, Aronowitz E, El Douahy Y, Leung R, Scherr DS, Ng A, Dominique D, Amiel J, Spincemaille P, Villers A, Ballon DJ.

BJU Int. 2016 May 7. doi: 10.1111/bju.13523. [Epub ahead of print]

PMID:
27154761
17.

NTSMDA: prediction of miRNA-disease associations by integrating network topological similarity.

Sun D, Li A, Feng H, Wang M.

Mol Biosyst. 2016 May 6. [Epub ahead of print]

PMID:
27153230
18.

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.

Bova GS, Kallio HM, Annala M, Kivinummi K, Högnäs G, Häyrynen S, Rantapero T, Kivinen V, Isaacs WB, Tolonen T, Nykter M, Visakorpi T.

Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000752. doi: 10.1101/mcs.a000752.

19.

Reevaluating PSA Testing Rates in the PLCO Trial.

Shoag JE, Mittal S, Hu JC.

N Engl J Med. 2016 May 5;374(18):1795-6. doi: 10.1056/NEJMc1515131. No abstract available.

PMID:
27144870
20.

Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.

Nelson AM, Gonzalez BD, Jim HS, Cessna JM, Sutton SK, Small BJ, Fishman MN, Zachariah B, Jacobsen PB.

Support Care Cancer. 2016 May 3. [Epub ahead of print]

PMID:
27142516
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk